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Early cutaneous lesions of erythema multiforme or 
mucosal lesions of the Stevens-Johnson syndrome con-
tain delicate granular deposits of immune reactants and/ 
or complement components lodged in the walls of vessels 
of the papillary dermis. Such deposits are not present in 
normal, unaffected skin although they can be caused to 
occur there by injection of substances which increase 
vascular permeability. Factors which cause accumula-
tion of mononuclear cells in the papillary dermis have 
not been elucidated but we suggest that receptors for the 
C3d fragment of the third component of complement 
could be responsible. Factors which cause intercellular 
edema in the epidermis, epidermal-dermal separation, 
or necrotic keratinocytes are unknown. 
We, and others, have now measured immune com-
plexes in the serum of patients experiencing these reac-
tion patterns by means of Raji cell radioimmunoassay, 
Clq precipitation, 1251-Clq binding, cryoprecipitation 
and with monoclonal rheumatoid factor. Cryoimmuno-
globulins have also been described and antigens of Her-
pesvirus hominus have been measured in the cryoprecip-
itate of 2 patients who experienced erythema multiforme 
following recurrent herpesvirus infection. 
Erythema multiforme commonly accompanied serum 
sickness reactions which occurred following injection of 
immune horse serum in the 1980s (von Pirquet and 
Schick). Such reactions are now well established as due 
to circulating immune complexes in antigen excess. 
By careful observation of skin lesions in his patients, Ferdi-
nand von He bra, in 1866, proposed that a number of cutaneous 
erythemas identified at that time could occur in the same 
individual over the course of time. Thus he proposed the name 
erythema (E.) multiforme to encompass the cutaneous reaction 
patterns formerly separated as E. papulatuin, E. tuberculatum, 
E. annulare, E. iris and E. gyratum. With evident discomfort, 
von He bra confessed he did not know the cause of this malady 
[1]. 
In recent years, some serious attempts have been made to 
define the histopathology of E. multiforme [2, 3]. There is 
invariably a mononuclear cell infiltrate in the dermis, predom-
inantly in a perivascular location. In addition, dermal edema 
and intercellular edema of the epidermis often occur with 
microvesiculation at the junction of t h e epidermis and dermis. 
Individually necrotic keratinocytes are observed and occasion-
ally islands of cells undergo necrosis. Although cell death may 
be extensive, we believe this phenomenon never approaches the 
total epidermal necrosis seen in the Lyell syndrome (toxic 
epidermal necrolysis) [ 4]. 
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The temporal relationship of erythema multiforme to drug 
ingestion, bacterial, viral, mycoplasmal, mycotic or protozoan 
infections, internal malignancies, or even potent contact sensi-
tizers [5] is well known. Indeed, the occurrence of E. multiforme 
7-14 days following su ch exposure led many to believe E. 
Multiforme was an allergic "reaction pattern" and not a disease 
sui generis. 
Recent evidence points to deposits in the superficial micro-
vasculature which resemble immune complexes [6]. We wish to 
extend our earlier fmdings in E. multiforme and present new 
data from patients with the Stevens-Johnson syndrome [7]. 
Moreover, we now report the presence of immune complexes in 
the serum ofpatientswith E. multiforme and Stevens-Johnson 
syndrome as measured by the Raji cell rad.ioimmune assay. 
MATERIALS AND METHODS 
Patients 
All patients were seen in the clinics or hospitals of The University of 
Oregon Health Sciences Center or the Portland Veterans Administra-
tion Hospital. Biopsies of lesions were generally performed less than 24 
hr after appearance, although in a few instances lesions were known to 
be from 2 to 10 days old. Normal skin was biopsied from the buttock 
before or 10 min after injection ofO.l cc histamine. Perilesional mucous 
membrane was biopsied in patients with Stevens-Johnson syndrome. 
368 
Immunofluorescence studies: Direct immunofluorescence was car-
ried out as described elsewhere [6]. 
Hemolytic complement (CH,..J: CHr.o determinations were cru-ried out 
as described by Mayer [8]. Normal values for our laboratory are 34.5 
± 6.75 (SEM) . 
Raji cell radioimmunoassay: We modified the Raji cell radioim-
munoassay to measure immune complexes not only of the lgG class 
[9] , but lgA or lgM as well . Positive controls consisted of purified 
human IgG globulin, human lgA myeloma or human IgM globu lin 
obtained from a patient with Waldenstrom macroglobulinemia. Purified 
immunoglobulins were aggregated by heating at 63°C. for 30 min. 
Proteins were measured by the Folin method or by extinction coeffi-
cient at 280 nm in a Zeiss PMQ II spectrophotometer. Aggregated 
immunoglobulin was incubated with fresh normal human serum, diluted 
1:2 with Spinners Salt Solu tion (SSS), as a source of complement. 
Raj i cells were obtained from the American Type Culture Collection 
and maintained in RPM! 1640 medium with added glutamine and fetal 
calf serum 10% heated 56°C. for 30 min. Expression of C3b and C3d 
receptors on Raj i cells was monitored every 2 weeks using heat aggre-
gated IgG, fresh complement and fluorescein-conjugated antiserum to 
C3 (Hyland). 
Antisera to human immunoglobulins were purchased from Calbi-
ochem-Behring and immunoglobulins were fUJ-ther purified on Protein 
A-Sephru·ose (Pharmacia) and eluted from the column with 3 M thio-
cyanate. The antisera to lgA lacked specificity in this assay until it was 
further purified by passage over an absorbent column containing lgM 
or IgG linked to CNBr-activated Sephru·ose. The problem which was 
overcome was apparently due to heavy absorption of the antisera and 
the presence within these antisera of unwanted complexes of the wrong 
immunoglobulin types. 
The assay itself consisted of adding 2 x lOu Raji cells in 50fLl SSS 
with 25 fLI patient's serum diluted 1:2 with SSS in a polypropylene tube 
with a conical tip (Sarstedt No. 477) . The tube was then incubated 45 
min at 37°C. with gentle shaking each 5-10 min by hand. The cells 
were then thrice washed with 1 ml SSS and reacted with an optimum 
amount of ' ~''!-rabbit antiserum to human lgG, IgA or lgM diluted 1:2 
with SSS contaning 1% serum albumin. After incubation 30 min at 
37°C., the tubes were transferred to an ice bath for an additional 30 
min and gently shaken. The cells were then washed 3 times with 1 ml 
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TABLE I. Results of direct immunofluorescence in E. nw.ltiforme and Stevens-Johnson syndrome 
Number positive for 
Tissue studied Number studied Immunoglobulin 
Number pos./num-
Complement Fibrin ber studied 
Erythema multiforme 
Lesional skin 
Assoc. with HSV 
Etiol. unknown 
Normal skin 
After histamine 
Stevens-Johnson syndrome 
Mucous membrane 
G 
8 0 
14 0 
5 0 
4 0 
4 0 
TABLE II. Statistical analysis of Raji cell radioimmune assay of 
serum specimens from patients with E. multiforme and Stevens-
Johnson syndrome 
Increased binding of 1"'1-rabbit antiserum to 
IgG lgA lgM 
Positive control (SLE) <0.001" NS <0.001 
Erythema multiforme 
Serum no. 
45 < 0.01 <0.001 <0.001 
63 <0.05 NS <0.001 
69 <0.001 <0.001 NS 
81 NS <0.001 <0.001 
83 < 0.001 NS <0.001 
84 NS NS < 0.001 
Stevens-Johnson syndrome 
Serum no. 
29 NS NS NS 
43 NS NS NS 
50 <0.001 <0.01 <0.001 
78 <0.001 < 0.001 NS 
"Significantly increased at p-value given, NS means not significant. 
SSS containing 1% HSA. Radioactivity of the cell pellett was then 
counted in an automated gamma counter. Each assay was performed 
in triplicate; 10 normal control sera were assayed for statistical analysis 
of the data. Negative controls either lacked human serum or contained 
normal human serum. Positive controls included aggregated human 
immunoglobulin described above or serum from patients with active 
systemic lupus erythematosus. 
All data was compared to results obtained with normal control sera 
performed the same day. Cell controls were subtracted. 
RESULTS 
A summary of results of direct immunofluorescence of skin 
lesions, normal skin or normal skin injected with histamine or 
mucosal biopsies in the Stevens-Johnson syndrome are given 
in Table I. In 8 of 25 patients studied, erythema multiforme 
followed a recurrence of Herpesvirus hominus. Delicate gran-
ular deposits, believed to be immune complexes, outlined the 
walls of vessels in the papillary dermis of the skin in 16 of 21 
patients with erythema multiforme. Similar deposits were seen 
in a mid-dermal location in 4 of 4 patients with the Stevens-
Johnson syndrome. Immunoglobulins were rarely observed and 
may have been masked by the binding of complement compo-
nents in the complex. IgM globulin only was detected in 7 of 
the 25 patients. 
Normal-appearing skin in 5 of these same patients was biop-
sied and no immune reactants of complement was found. Fol-
lowing histamine injection, however, 3 of 4 biopsies of normal 
skin revealed granular deposits of C3 lodged in the microvas-
culature, primarily in the mid-dermis or surrounding hair folli-
cles. These findings suggested to us that immune complexes in 
erythema multiforme are probably circulating and do not form 
locally in tissue. 
The results of the Raji cell radioimmunoassay are given in 
Table II. Eight of 10 serum specimens, each from different 
individuals, were positive for one or more immunoglobulins 
A M 
C3 
0 3 6 3 6/ 8 
0 4 10 2 10/ 14 
0 0 0 0 0/ 5 
0 0 3 0 3/ 4 
0 0 4 1 4/ 4 
significantly increased from normal control serum. In 7 of the 
8, two or more immunoglobulins were significantly elevated. 
DISCUSSION 
Work done during the past few years suggests that part of 
the pathologic changes in erythema multiforme, and now in 
Stevens-Johnson syndrome as well, are attributable to the 
deposition of immune complexes in skin or mucous membrane. 
Research from our laboratory as well as from others will be 
briefly discussed. However we must also give attention to other 
aspects of the pathologic alterations occurring in the tissues 
which are less readily explained by immune complexes becom-
ing deposited in the walls of vascular channels in the superficial 
microvasculature. What factors determine the characteristic 
types of cells which emigrate into the dermis? Why do the 
immune deposits not become swept through the subendothelial 
basal lamina towards the dermal-epidermal inte1face? What is 
responsible for keratinocyte necrosis, which may occur either 
singly or in small nests? Finally what properties characterize 
the deposits in erythema multiforme so that effects upon inter-
nal organs is so relatively inconsequential? 
The work reported here expands and extends our discovery 
of immune reactants in the microvasculature in erythema mul-
tiforme [6]. Such deposits are found in over 75% of lesions thus 
far tested; they are present in all lesions biopsied less than 24 
hr after their appearance. Older lesions, present 2-10 days, are 
usually negative, probably because of endocytosis and degra-
dation of the complexes by inflammatory cells. Presumably, 
this is the reason for negative reports by earlier workers [10-
12]. The Stevens-Johnson syndrome, the counterpart of ery-
thema multiforme occwTing simultaneously or exclusively on 
mucosal surfaces, was also shown to have immune reactants in 
4 of 4 biopsies. 
A variety of tests capable of detecting immune complexes 
have been applied to the study of serum from patients with 
erythema multiforme; C1q precipitation in agar [13, 14], cry-
oprecipitation [15], 125I-C1q precipitation with polyethylene 
glycol [15], monoclonal rheumatoid factor and Raji cell radioim-
mune assay, described here. 
In 1971, Agnello described a single patient with erythema 
multiforme and a Clq precipition of low molecular weight 
[13]. The patient had markedly depleted components of the 
classical pathway, Cl, C4, C2 as well as C3 depletion. The C1q 
precipitin was 7S and was destroyed by reduction and alkylation 
or by incubation with pronase. With administration of gluco-
corticoids, the C1q precipitating material largely disappeared 
from the serum and the skin eruption cleared. It is not known 
whether the histological changes were compatible with ery-
thema multiforme; biopsy information was not reported. A 
similar case was described by Oishi et al in 1976 associated with 
hypocomplementemia and a low molecular weight precipitin 
(14] which was associated with a syndrome similar to systemic 
lupus erythematosus. We have studied CH50 levels in only 3 
patients to date, and the results have been at the lower normal 
values yet not statistically significant from controls. Marked 
hypocomplementemia would appear to be the exception, not 
the rule, in erythema multiforme. 
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Swinehart and co-workers recovered cryoimmunoglobulins 
in cryoprecipitates in 9 of 10 patients with erythema multi-
forme. IgM was present in 9, IgA in 6 and IgG in 4 patients 
[15]. Herpesvirus hominus antigens were later reported in 
cryoprecipitates in 2 of 13 patients and in the serum of 5 of 13 
[16]. 
Elevated 125l-C1q binding was described in 11 of 26 patients 
studied by Huff et al [16]. Mackel and Jordon have reported 
increased 125I-C1q binding as well as increased 1251-monoclonal 
rheumatoid factor binding in patients with mononuclear cell 
vasculitis, including erythema multiforme. 
The results of Raji cell radioimmune assay in 10 patients 
studied by us were positive in 8 individuals with cutaneous and/ 
or mucosal erythema multiforme. 
Safai, Good and Day found depletion of complement com-
ponents in the blister fluids of two patients with bullous E. 
multiforme and speculated, on that basis, about an immunologic 
pathogenesis [17]. 
Thus, many of the current methodologies for measurement 
of circulating immune complexes have yielded positive infor-
mation that E. multiforme is consistent with a circulating 
immune complex disorder. As is so often the case, identification 
of critical antigens in a putative IC has not been done, except 
for the studies of Huff et al [16]. Because Herpesvirus hominus 
causes an estimated 15% of instances of E. multiforme, this 
becomes a useful model for intensive study of this disease. 
Is E. multiforme a vasculitis? First of all, we believe that in 
about 25% of instances vascular channels are breached; eryth-
rocytes leak and coagulation occurs into the surrounding der-
mis. One criterion of vascular injury is fibrin deposits in the 
dermis, found in 7 of 25 instances in our series. Vascular injury 
to the point of disruption of the vascular wall occms in 15-25% 
of cases when evaluated by routine histopathology or immu-
nofluorescence and may reflect the intensity of the inflamma-
tory process. 
Why do mononuclear cells accumulate in E. multiforme? We 
suggested [6], but have not yet proven that the physicochemical 
natme of the IC deposited may determine the cellular nature 
of the inflammatory cells which predominate in this reaction. 
Human neutrophilic granulocytes have receptors for C3b and 
these cells predominate in other angiitidies called "leukocyto-
clastic vasculitis." However, in E. multiforme, it may be that 
immune reactants bear C3d, as modified by the C3b-inactivator 
and ,B1H globulin, m.ay be deposited in lesional sites and attract 
only cells with C3d receptors; namely, monocytes and lympho-
cytes. This hypothesis should be testable when appropriate 
antisera become available. 
Although a variety of erythematous disorders are recognized 
(Table III), only a few have been studied for immune complexes. 
Positive findings have been reported in E. multiforme, E. no-
dosum, E. chronicum migrans and E. elevatum diutinum. We 
have recently studied 2 pubertal girls with E. scarlatiniforme 
during the acute phase of their illness. Neither has demon-
strated immune reactants in skin or immune complexes in 
serum (unpublished data). 
Why are immune reactants in E. multiforme and Stevens-
Johnson syndrome almost always found in vessel walls? In a 
few instances, we have observed minimal deposits near the 
junction of the epidermis and dermis, but characteristically the 
deposits are in vessel walls. Yen and Braverman demonstrated 
they could distinguish between the arterial and venous sides of 
the microcirculation by the ultrastructural characteristics of 
the subendothelial basement membrane [22]. The deposits we 
have observed in some patients would appear to be localized 
both in the ascending and the descending segments of these 
capillary loops. Perhaps the size of these complexes is suffi-
ciently large that they are unable to pass the basement mem-
brane and enter the dermis. Of note is the multiple immuno-
globulins detected in most patients by the Raji cell assay and 
the frequency with which IgM globulin is associated with the 
complexes. We are currently studying the sedimentation behav-
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TABLE III. The cutaneous erythemas 
E . simplex 
E. multiforme 
E. papulatum 
E. tuberculatum 
E. a nnulare 
E. iris 
E. gyratum 
E. caloricum 
E. ab igne 
E. solare 
E. pernio 
E. chronicum migrans 
E. scarlatiniforme 
E. annu lare centrifugum 
E. marginatum 
E. nodosum 
E. induratum 
E. elevatum diutinum 
Evidence for immune 
complex etiology 
NT 
Yes (6, 13-17)" 
NT 
Yes (18, 19) 
No 
NT" 
NT 
Yes (20) 
NT 
Yes (21) 
" Numbers in parentheses indicate references. 
1
' NT = not tested. 
The course of serum sickness in a young child following injection of 
200 cc horse anti-streptococcal antiserum. Note the apperu·ance of 
erythema multiforme on day 12 (from Die Serumkrankheit, Fig. XII, 
Franz Deuticke, Leipzig und Wein). 
ior of E. multiforme sera to ascertain the composition and size 
of the complexes. 
Individually altered keratinocytes or nests of keratinocytes 
stain abnormally with H&E and appear "necrotic." The nature 
and mechanism of the changes in these cells is completely 
unknown. 
Injury to internal organs; e.g., brain , heart, lung or kidney is 
uncommon in association with E. multiforme. It is not yet clear 
whether some injury is subclinical or whether it fails to occcw· 
at all. When immune horse serum was used for the treatment 
of scarlet fever or diphtheria in the 1890s, von Pirquet and 
Schick observed significant systemic illness [23]. They were so 
impressed with this, they changed the name of the reactions 
that accompanied horse serum injections from Serum exanthe-
mata to Serumkrankheit. The Figure is reproduced from the 
English translation of their book published in 1905. Note that 
on day 1, 4-yr old Egon E was febrile and he received 200 cc of 
antistreptococcal horse serum. He improved until day 8 when 
he began to retain fluid, experienced swelling of lymph nodes, 
became febrile and developed urticaria. On day 12 he developed 
E. multiforme which persisted an additional week until the 
entire reaction subsided. If von Pirquet had only known the 
mechanism of Serumkrankheit, he might have suggested E. 
multiforme might be an immune complex erythema. 
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Announcement 
The Fifth Annual Postgraduate Course in Pediatric Dermatology, cosponsored by the Society for 
Pediatric Dermatology and Stanford University's Department of Dermatology, will be held August 7-9, 
1980, at the Doubletree Inn in Monterey, Califorma. It is open to all physicians and h ealth care personnel 
concerned with skin diseases in children. The meeting will emphasize specific areas in pediatric derma-
tology through didactic sessions, case presentations, clinical pathologic conferences and discussion groups. 
This is an AMA accredited postgraduate seminar. For information, please contact: Paul H. Jaco bs, M.D. , 
Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, (415) 497-
6101. 
